首页> 外文OA文献 >PHP31 FDA breakthrough Therapy status - a systematic analysis of all Therapies approved under this new expedited Approval Pathway

【2h】

PHP31 FDA breakthrough Therapy status - a systematic analysis of all Therapies approved under this new expedited Approval Pathway

机译：PHP31 FDA突破性治疗状态-对根据该新的快速批准途径批准的所有治疗方法的系统分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Macaulay R.;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Expediting drug development - The FDA's new "breakthrough therapy" designation [J] . ShermanR.E., LiJ., ShapleyS., The New England journal of medicine . 2013,第20期

机译：加快药物开发-FDA的新“突破性疗法”称号
2. Considerations and Regulatory Challenges for Innovative Medicines in Expedited Approval Programs: Breakthrough Therapy and Sakigake Designation [J] . Kajiwara Eiji, Shikano Mayumi Therapeutic innovation & regulatory science. . 2020,第4期

机译：加急批准方案中创新药物的考虑因素和监管挑战：突破治疗和索克指定
3. Clinical Trial Evidence Supporting FDA Approval of Drugs Granted Breakthrough Therapy Designation [J] . Puthumana Jeremy, Wallach Joshua D., Ross Joseph S. JAMA: the Journal of the American Medical Association . 2018,第3期

机译：支持FDA批准药物的临床试验证据授予突破治疗指定
4. Dose enhancement during concomitant chemoradiotherapy using FDA approved concentrations of carboplatin and oxaliplatin nanoparticles [C] . Gizem Cifter, Yucel Altundal, Alex Detappe World Congress on Medical Physics and Biomedical Engineering . 2015

机译：使用FDA批准的Carboplatin和Oxaliplatin纳米粒子伴随的伴随化学疗法期间的剂量增强
5. The Efficacy of Extracorporeal Shock Wave Therapy in Comparison to Low-Level Laser Therapy for Decreasing Pain and Symptom Severity and Increasing Functional Status in Adult Patients with Carpal Tunnel Syndrome: A Systematic Review and Meta-Analysis [D] . Seely, Andrew. 2021

机译：体外冲击波治疗与低水平激光治疗对脑隧道综合征的成人患者疼痛和症状严重程度及函数状况的疗效：系统评价与荟萃分析
6. Comparative Risks of High-Grade Adverse Events Among FDA-Approved Systemic Therapies in Advanced Melanoma: Systematic Review and Network Meta-Analysis [O] . Ya-fang Huang, Wen-jie Xie, Hai-yu Fan, 2020

机译：FDA批准的高级素疗法中高级不良事件的比较风险在先进的黑色素瘤中：系统审查与网络元分析
7. PHP26 Breakthrough Therapy status â€“ expedited FDA regulatory approval but what about the payers? [O] . Macaulay R., Cost P. 2015

机译：PHP26突破疗法状态–加快了FDA监管批准，但是付款人呢？

PHP31 FDA breakthrough Therapy status - a systematic analysis of all Therapies approved under this new expedited Approval Pathway

著录项

引文网络

相似文献

相关主题

期刊订阅